Robert Hadfield - Net Worth and Insider Trading

Robert Hadfield Net Worth

The estimated net worth of Robert Hadfield is at least $2,169 dollars as of 2024-11-13. Robert Hadfield is the General Counsel and Secretary of Alaunos Therapeutics Inc and owns about 889 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $2,169. Details can be seen in Robert Hadfield's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Hadfield has not made any transactions after 2021-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Hadfield

To

Robert Hadfield Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Hadfield owns 2 companies in total, including Alaunos Therapeutics Inc (TCRT) , and Salarius Pharmaceuticals Inc (SLRX) .

Click here to see the complete history of Robert Hadfield’s form 4 insider trades.

Insider Ownership Summary of Robert Hadfield

Ticker Comapny Transaction Date Type of Owner
TCRT Alaunos Therapeutics Inc 2021-01-08 General Counsel and Secretary
SLRX Salarius Pharmaceuticals Inc 2015-01-28 General Counsel & Secretary

Robert Hadfield Latest Holdings Summary

Robert Hadfield currently owns a total of 1 stock. Robert Hadfield owns 889 shares of Alaunos Therapeutics Inc (TCRT) as of January 8, 2021, with a value of $2,169.

Latest Holdings of Robert Hadfield

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRT Alaunos Therapeutics Inc 2021-01-08 889 2.44 2,169

Holding Weightings of Robert Hadfield


Robert Hadfield Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Hadfield has made a total of 2 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alaunos Therapeutics Inc is the sale of 177 shares on January 8, 2021, which brought Robert Hadfield around $82,680.

Insider Trading History of Robert Hadfield

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Hadfield Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Hadfield Ownership Network

Ownership Network List of Robert Hadfield

No Data

Ownership Network Relation of Robert Hadfield

Insider Network Chart

Robert Hadfield Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Robert Hadfield is the General Counsel and Secretary of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Robert Hadfield made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alaunos Therapeutics Inc Insider Transactions

No Available Data

Robert Hadfield Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Hadfield. You might contact Robert Hadfield via mailing address: C/o Flex Pharma, Inc., 800 Boylston Street, 24th Floor, Boston Ma 02199.